Colgate-Palmolive (NYSE:CL) Price Target Raised to $122.00 at UBS Group

Colgate-Palmolive (NYSE:CLFree Report) had its price objective lifted by UBS Group from $119.00 to $122.00 in a report issued on Wednesday morning, Benzinga reports. The firm currently has a buy rating on the stock.

Several other equities analysts have also recently weighed in on CL. Sanford C. Bernstein raised their target price on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a market perform rating in a research note on Tuesday, July 30th. Wells Fargo & Company lifted their target price on Colgate-Palmolive from $92.00 to $97.00 and gave the stock an equal weight rating in a report on Wednesday, July 10th. Evercore ISI increased their price target on Colgate-Palmolive from $100.00 to $106.00 and gave the company an outperform rating in a research note on Thursday, July 18th. Deutsche Bank Aktiengesellschaft lifted their price objective on Colgate-Palmolive from $104.00 to $107.00 and gave the stock a buy rating in a research note on Monday, July 29th. Finally, Argus raised their target price on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the company a buy rating in a report on Wednesday, May 15th. Eight investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of Moderate Buy and an average price target of $102.53.

Get Our Latest Stock Analysis on CL

Colgate-Palmolive Price Performance

NYSE CL opened at $108.74 on Wednesday. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.90. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $108.98. The stock has a market cap of $89.21 billion, a price-to-earnings ratio of 34.41, a PEG ratio of 3.73 and a beta of 0.39. The company’s 50 day moving average is $100.65 and its two-hundred day moving average is $94.18.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The company had revenue of $5.06 billion for the quarter, compared to analysts’ expectations of $5 billion. During the same quarter in the previous year, the company earned $0.77 EPS. Colgate-Palmolive’s revenue for the quarter was up 4.9% on a year-over-year basis. As a group, research analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.84%. The ex-dividend date of this dividend was Friday, July 19th. Colgate-Palmolive’s payout ratio is currently 63.29%.

Insiders Place Their Bets

In other news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the sale, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. The disclosure for this sale can be found here. Insiders have sold a total of 43,490 shares of company stock worth $4,486,063 over the last quarter. Company insiders own 0.34% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. KPP Advisory Services LLC boosted its stake in shares of Colgate-Palmolive by 6.3% during the second quarter. KPP Advisory Services LLC now owns 8,899 shares of the company’s stock valued at $864,000 after purchasing an additional 525 shares in the last quarter. Ariadne Wealth Management LP bought a new stake in Colgate-Palmolive during the 2nd quarter valued at $1,474,000. 3Chopt Investment Partners LLC purchased a new position in shares of Colgate-Palmolive in the 2nd quarter valued at $400,000. SPC Financial Inc. purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $227,000. Finally, EP Wealth Advisors LLC boosted its position in Colgate-Palmolive by 1.7% during the second quarter. EP Wealth Advisors LLC now owns 43,863 shares of the company’s stock valued at $4,256,000 after purchasing an additional 726 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.